Skip to content
10-Q

Quarterly Report

BIONIK LABORATORIES CORP.

0001410578-23-000074

← back to feed
Filed
Feb 8, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Feb 3, 2023 6.88M sh
Shares Diluted Q3 2023 · Dec 31, 2022 6.88M sh
Shares Diluted Q3 2023 · Dec 31, 2022 6.88M sh
Shares Diluted Q3 2023 · Dec 31, 2021 5.9M sh
Shares Diluted Q3 2023 · Dec 31, 2021 5.82M sh
Capex Q3 2023 · Dec 31, 2022 $7.94K
Operating Cash Flow Q3 2023 · Dec 31, 2022 −$2.63M
Operating Cash Flow restated Q3 2023 · Dec 31, 2021 −$2.77M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $685.2K
Cash And Equivalents Q3 2023 · Mar 31, 2022 $1.99M
Stockholders Equity Q3 2023 · Dec 31, 2022 −$521.91K
Stockholders Equity Q3 2023 · Mar 31, 2022 $2.93M
Current Liabilities Q3 2023 · Dec 31, 2022 $2.09M
Current Liabilities Q3 2023 · Mar 31, 2022 $1.49M
Total Liabilities Q3 2023 · Dec 31, 2022 $4.21M
Total Liabilities Q3 2023 · Mar 31, 2022 $1.75M
Current Assets Q3 2023 · Dec 31, 2022 $3.08M
Current Assets Q3 2023 · Mar 31, 2022 $4.58M
Total Assets Q3 2023 · Dec 31, 2022 $3.69M
Total Assets Q3 2023 · Mar 31, 2022 $4.68M
Eps Diluted Q3 2023 · Dec 31, 2022 −$0.16
Eps Diluted Q3 2023 · Dec 31, 2022 −$0.52
Eps Diluted restated Q3 2023 · Dec 31, 2021 −$1.18
Eps Diluted restated Q3 2023 · Dec 31, 2021 −$1.50
Eps Basic Q3 2023 · Dec 31, 2022 −$0.16
Eps Basic Q3 2023 · Dec 31, 2022 −$0.52
Eps Basic Q3 2023 · Dec 31, 2021 −$1.18
Eps Basic Q3 2023 · Dec 31, 2021 −$1.50
Sga Expense Q3 2023 · Dec 31, 2022 $773.91K
Sga Expense Q3 2023 · Dec 31, 2022 $2.06M
Sga Expense Q3 2023 · Dec 31, 2021 $725.3K
Sga Expense Q3 2023 · Dec 31, 2021 $2.22M
Rd Expense Q3 2023 · Dec 31, 2022 $93.62K
Rd Expense Q3 2023 · Dec 31, 2022 $697.6K
Rd Expense Q3 2023 · Dec 31, 2021 $368.1K
Rd Expense Q3 2023 · Dec 31, 2021 $634.15K
Net Income Q3 2023 · Dec 31, 2022 −$1.08M
Net Income Q3 2023 · Dec 31, 2022 −$3.59M
Net Income Q3 2023 · Dec 31, 2021 −$6.98M
Net Income Q3 2023 · Dec 31, 2021 −$8.7M
Operating Income Q3 2023 · Dec 31, 2022 −$1.04M
Operating Income Q3 2023 · Dec 31, 2022 −$3.53M
Operating Income Q3 2023 · Dec 31, 2021 −$6.73M
Operating Income Q3 2023 · Dec 31, 2021 −$8.57M
Gross Profit Q3 2023 · Dec 31, 2022 $270.55K
Gross Profit Q3 2023 · Dec 31, 2022 $735.76K
Gross Profit Q3 2023 · Dec 31, 2021 $132.87K
Gross Profit Q3 2023 · Dec 31, 2021 $820.63K
Cost Of Revenue Q3 2023 · Dec 31, 2022 $304.5K
Cost Of Revenue Q3 2023 · Dec 31, 2022 $568.33K
Cost Of Revenue Q3 2023 · Dec 31, 2021 $50.39K
Cost Of Revenue Q3 2023 · Dec 31, 2021 $261.82K
Revenue Q3 2023 · Dec 31, 2022 $575.05K
Revenue Q3 2023 · Dec 31, 2022 $1.3M
Revenue Q3 2023 · Dec 31, 2021 $183.26K
Revenue Q3 2023 · Dec 31, 2021 $1.08M
Stock Issued Q3 2023 · Feb 25, 2015 1.75K sh